Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series

• click to rate

  Posted by Two Blokes Jul 23 - Filed in Stock - 9 views
  
  SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the H.C. Wainwright “HCW@Home” Series.